Conversion to sirolimus in African American renal allograft recipients undergoing early steroid withdrawal: intermediate-term risks and benefits.

Gruber, Scott A

Conversion to sirolimus in African American renal allograft recipients undergoing early steroid withdrawal: intermediate-term risks and benefits. [electronic resource] - Transplantation May 2010 - 1161-2 p. digital

Publication Type: Letter; Comment

1534-6080

10.1097/TP.0b013e3181d1f238 doi


Adrenal Cortex Hormones--therapeutic use
Adult
Antibodies, Monoclonal--therapeutic use
Antilymphocyte Serum
Black People
Drug Administration Schedule
Female
Follow-Up Studies
Hepatitis C--epidemiology
Humans
Immunosuppressive Agents--therapeutic use
Kidney Transplantation--immunology
Male
Methylprednisolone--therapeutic use
Middle Aged
Mycophenolic Acid--analogs & derivatives
Renal Dialysis
Reoperation--statistics & numerical data
Risk Assessment
Sirolimus--therapeutic use
Tacrolimus--therapeutic use
Transplantation, Homologous
Black or African American